The effect of glucose variability, as assessed by continuous glucose monitoring system, on cardiovascular disease

The effect of glucose variability, as assessed by continuous glucose monitoring system, on cardiovascular disease - The effect of glucose variability on cardiovascular disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010620

Enrollment

100

Registered

2013-04-30

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients aged 20 years old or older at the time of consent. 2)Patients with cardiovascular disease. 3)Patients providing written consent for participation in this study on their own volition after receving a through explanation about the study.

Exclusion criteria

Exclusion criteria: 1) Patients with unwillingness to participate or Patients whose conset could not be aquired. 2)Patients judged to be unsuitable for participation for medical reason.

Design outcomes

Primary

Measure	Time frame
To evaluate the relationship of glucose variability to clinical parameters such as biomarker, cardiac function and atherosclerotic plaque, etc.in patients with acute coronary syndromes.	—

Secondary

Measure	Time frame
The relationship between the glucose variability and short- and long-term prognosis (death, non-fatal myocardial infarction, unstable angina, restenosis, heart failure,etc)	—

Countries

Japan

Contacts

Public ContactYohei Hanashima

Yokohama City University Medical Center Devision of Cardiology

yugo@yokohama-cu.ac.jp045-261-5656

Outcome results